Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX – Get Free Report) was the recipient of a large drop in short interest in the month of January. Radiopharm Theranostics Stock PerformanceShares of NASDAQ RADX traded up $0.06 during mid-day trading on Wednesday, reaching $4.98. Get Radiopharm Theranostics alerts:Hedge Funds Weigh In On Radiopharm TheranosticsAn institutional investor recently raised its position in Radiopharm Theranostics stock. PNC Financial Services Group Inc. owned approximately 0.20% of Radiopharm Theranostics worth $88,000 as of its most recent SEC filing. See AlsoReceive News & Ratings for Radiopharm Theranostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radiopharm Theranostics and related companies with MarketBeat.com's FREE daily email newsletter.